In a medical milestone decades in the making, a gene-altering leukemia therapy got a unanimous vote of confidence from an F.D.A. panel

A Food and Drug Administration panel opened a new era in medicine on Wednesday, unanimously recommending that the agency approve the first-ever treatment that genetically alters a patient’s own cells to fight leukemia, transforming them into what scientists call “a living drug” that powerfully bolsters the immune system to shut down the disease.

Read More »